Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 4471-4480 Newer>

Managed Care December 2007	Strong Support for Transparency, But Small Effect Expected on Costs Three quarters of health care leaders believe increased transparency -- the public reporting of quality and pricing by name of hospital, physician practice, or health care provider -- is essential to improve the performance of the United States' health care system, according to a survey.
Managed Care December 2007	Privately Insured Use Emergency Room Less A recently issued brief from the Henry J. Kaiser Family Foundation seeks to characterize and analyze persons who frequently, or infrequently, use hospital emergency department.
Managed Care December 2007	Medical Directors' Pay up 37% Since `97 -- or Not Salaries of medical directors and associate/assistant medical directors have risen by more than 30% over the last 10 years, according to a 2007 survey.
Managed Care December 2007	Insurers Lean Toward Generic Alternatives More insurers are focusing their attention on a second approach to generic drug management -- generic alternatives, which contain different active ingredients, but have comparable efficacy to brand-name drugs in the same class.
The Motley Fool January 3, 2008 Brian Orelli	8 Generic-Drug Makers for 2008 Generic-drug makers can predict the growth of their industry, because it's written right in the patent-expirations column of the FDA's orange book. Here's a brief look at eight generic-drug makers worth closer scrutiny.
The Motley Fool January 3, 2008 Brian Orelli	A Super Superbug Testing Market Becton, Dickinson gets FDA approval of its quick blood test for MRSA, the so-called superbug.
Chemistry World January 2008 Derek Lowe	Column: In the Pipeline It's been a rough year, but the future looks bright for pharma.
The Motley Fool January 2, 2008 Brian Orelli	Congestion in the OTC Market J&J already has generic competition for its new drug Zyrtec.
The Motley Fool December 31, 2007 Brian Lawler	The Anatomy Of An Approved Drug An independent audit by the FDA provides a useful summary of the characteristics of drugs approved by the agency.
The Motley Fool December 31, 2007 Brian Lawler	Cephalon's Date With the FDA In the last day of the year, Cephalon announces that it has submitted another New Drug Application for oncology treatment Treanda. Expect to hear back from FDA on this priority review before the middle of 2008.
<Older 4471-4480 Newer> Return to current articles.